Sign In
Buy IBIO
$1.84
+0.0800 (+4.55%)
At Close: Jun 03, 2026
iBio Announces Closing of $3.5 Million Underwritten Public Offering
09:05pm, Friday, 09'th Dec 2022 GlobeNewswire Inc.
BRYAN, Texas, Dec. 09, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced the closing
7 Penny Stocks to Sell Before They Plunge in 2023
02:32pm, Thursday, 08'th Dec 2022
2022 was a terrible year for the stock market. Fortunately for 2023, news of lower interest rate hikes hints at a new bull market.
Dow Edges Higher; Prometheus Biosciences Shares Jump
07:43pm, Wednesday, 07'th Dec 2022 Benzinga
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 0.5% on Wednesday.
The Dow traded up 0.03% to 33,606.83 while the NASDAQ fell 0.41% to 10,969.66. The S&P
Why Prometheus Biosciences Shares Are Trading Higher By Over 184%? Here Are 55 Stocks Moving In Wednesday's Mid-Day Session
06:45pm, Wednesday, 07'th Dec 2022 Benzinga
Gainers
Prometheus Biosciences, Inc. (NASDAQ: RXDX) shares jumped 184.2% to $102.49 after the company announced results for PRA023 in both ARTEMIS-UC Phase 2 and APOLLO-CD Phase 2a studies. ARTEMIS-
Nasdaq Drops 75 Points; Crude Oil Down 2%
05:16pm, Wednesday, 07'th Dec 2022 Benzinga
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping 75 points on Wednesday.
The Dow traded down 0.22% to 33,521.11 while the NASDAQ fell 0.68% to 10,939.93. The S&P 500
Why iBio Shares Are Trading Lower By Around 48%; Here Are 23 Stocks Moving Premarket
12:41pm, Wednesday, 07'th Dec 2022 Benzinga
Gainers
TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares rose 71.3% to $0.7190 in pre-market trading after the company reported withdrawal of registration statement.
The Very Good Food Company Inc.
iBio Announces Pricing of $3.5 Million Underwritten Public Offering
04:27am, Wednesday, 07'th Dec 2022 GlobeNewswire Inc.
BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced the pricing
iBio Announces Proposed Underwritten Public Offering
09:01pm, Tuesday, 06'th Dec 2022 GlobeNewswire Inc.
BRYAN, Texas, Dec. 06, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA: IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced it intends t
iBio Announces CEO Departure
09:30pm, Friday, 02'nd Dec 2022 GlobeNewswire Inc.
BRYAN, Texas, Dec. 02, 2022 (GLOBE NEWSWIRE) -- iBio, Inc. (NYSEA:IBIO) (“iBio” or the “Company”), an AI-driven innovator of precision antibody immunotherapies, today announced the Board of
7 Penny Stocks to Sell Pronto Before a Painful Downturn
06:40pm, Thursday, 27'th Oct 2022
It has been a rough year for investors, with the S&P 500 index posting incredible losses not seen in some time. As stocks continue to hover in this fragile market, investors must consider which assets
7 Short-Squeeze Stocks to Sell Before Traders Cash Out
02:21pm, Wednesday, 19'th Oct 2022
Although contrarianism captured headlines through the first two years of the coronavirus pandemic, it's now time for investors to consider the topic of short-squeeze stocks to sell before traders cash
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
07:20am, Wednesday, 12'th Oct 2022 Benzinga
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.
DICE Therapeutics, Inc. (NASDAQ: DICE) shares gained 62.3% to close at $40.00 after the company an
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
04:44pm, Tuesday, 11'th Oct 2022 Benzinga
Gainers
FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939.
Laser Photonics Corporation (NASDAQ: LASE) rose 62.1% to $3.0314 after the company announced it received an order from th
3 Healthcare Stocks to Sell Before They Die
11:48am, Friday, 30'th Sep 2022
The Fed's key interest rate target now stands at 3%-3.25%, way up from 0%-0.25% at the beginning of the year. That means, for all companies, borrowing money is becoming much more expensive.
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
09:09am, Thursday, 29'th Sep 2022 Benzinga
Gainers
PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The tria
